← All trials
NCT03227731
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 28, 2017
- Primary completion
- Jun 30, 2020
- Completion date
- Jun 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 842
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Kwa-Zulu NatalLead sponsor
- University of Kwa-Zulu NatalReponsible party - principal investigator
- University of Kwa-Zulu NatalOverall official - principal investigator
- Centre for the AIDS Programme of Research in South AfricaCollaborator
- Medical Research Council, South AfricaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.